This case highlights the importance of considering endogenous hyperthyroidism in post-ablative hypothyroid patients receiving thyroid hormone replacement therapy who exhibit persistent biochemical thyrotoxicosis despite dose reduction and discontinuation, and underscores the diagnostic value of thyroid autoantibody testing in conjunction with clinical presentation in establishing disease recurrence. Here, TG is linked to hyperthyroidism.